The highly expressed genes fall in upper, more flat region of the binding curve, while the low expressers are in the most linear response region.
The high affinity binding site mediates binding to the homodimer EPO receptor and is responsible for the haematopoietic response, while the low affinity binding site mediates binding to the EPO receptor - common β receptor heterotrimer complex, a interaction, which has been proposed to be responsible for the pleiotropic effects of EPO [30].
LiSiCA thus proved its ability for obtaining compounds with diverse scaffolds, while the low binding-efficiency index of the structures enables their further optimization.
At physiological pH, Zn II) is terminally bound to the cysteine thiols of MT2a, making bead-like structures (non-cooperative metal binding), while at low pH, Zn II) formed Zn4S11-MT2a clusters involving bridged cysteinyl thiols to the Zn II) (cooperative metal binding).
In conclusion, we show for the first time that robust mCrem expression allows Cre activity independent of ligand binding, while low mCrem expressing clones are largely free of this effect, and that tamoxifen/OHT dose response correlates with changing mCrem expression.
The trade provisions of the TPP are binding while the provisions of the COP21 climate agreement are not.
These functional coatings should have the ability to specifically bind (bio molecules with a high binding efficiency, while showing low unspecific binding during the following assay.
Moderate inhibition of the Emax by THG113.31 suggested that FDA binding to PGF2α receptor produced moderate degree of contraction while the lowest inhibition by atropine suggested that FDA binding to the muscarinic receptor produced the least degree of contraction.
While the lowest are among students.
A report indicates that sIL-1RAcP associates as ligand-bound to type II sIL-1R, increasing the binding affinity of IL-1α and IL-1β to type II sIL-1R by approximately 100-fold, while leaving unaltered the low binding affinity of IL-1Ra typeype II sIL-1R, thus enhancing inhibition of IL-1 when both IL-1Ra and sIL-1RAcP are present [ 52].
